Rescrito
About Rescrito
Rescrito is an AI-powered platform designed for academic research and writing, assisting students and researchers in creating essays, reports, and other scholarly documents. The tool helps users define their research focus, organize sources, and write clear, coherent chapters. It is particularly useful for final projects, theses, articles, and reports where structure and rigor are essential. Rescrito offers features such as generating citations, summarizing articles, and analyzing PDFs to extract key evidence, making it suitable for researchers, professionals, and educators alike.
The platfor…
Commercially, Rescrito is a working SaaS: it reported $5,094 in the last 30 days, has $6,353 in recurring revenue, and an unusually high reported margin of 80%, which suggests a lean cost base or favorable pricing. Having paying customers and positive margin at this stage is a real strength for an early AI product. The company was founded on 2024-07-11 and operates from ES.
Signals to probe: growth declined by -20% in the last 30 days while there are still 36,373 monthly visitors, which points to a gap between demand (traffic) and monetization or retention. The fact that MRR exceeds last-30-day revenue could reflect billing timing or churn/discounting dynamics — worth clarifying. The listing-for-sale status adds an extra strategic dimension (founder exit or liquidity need) that buyers should factor into valuation and transition risk.
— Strengths
— What to watch
◆ Best suited for
A judgment from project data — not a user review.
